XenoPort to Present New Data for Novel Fumarate Analog XP23829 and HORIZANT at the 66th Annual Meeting of the American …
XenoPort to Present New Data for Novel Fumarate Analog XP23829 and HORIZANT at the 66th Annual Meeting of the American …
XenoPort, Inc. announced today that it will present data on its investigational and marketed therapies for neurological diseases at the 66th Annual Meeting of the American Academy of Neurology in Philadelphia. Causes of Drug Abuse – Yahoo News Search Results